U.S.
Performance of Carmakers’ Pedestrian Detection Systems Varies Widely: IIHS
The performance of modern pedestrian detection systems varies widely between carmakers, with high-end luxury brands generally faring better and other models failing to recognize pedestrians ...
Executives On The Move at Beazley, Ascot and Chisel AI
Beazley hired two new executives charged with beefing up its U.S. commercial insurance operations, and a third focused on medical professional liability risks. Ascot appointed two individuals who ...
Munich Re America’s Levy: ‘Stable’ Expectations for the Future Reinsurance Market
Reinsurers are getting higher rates, and there's continued pressure on ceding commissions. But demand for reinsurance cover should remain stable even as prices increase, according to Munich Re ...
Ransomware Attacks Soaring as They Target IT Vendors and Their Clients
Ransomware attacks increased by 37 percent during the third quarter of 2019 compared to Q2, as cyber criminals target both IT vendors and their clients, according to data compiled by insurer Beazley. ...
Everest Re’s Q3 Net Income Slammed by Hurricane Dorian, Typhoon Faxai
Hurricane Dorian and Typhoon Faxai chipped away at Everest Re Group's 2019 third-quarter net income, knocking it nearly in half from the previous year. The Bermuda-based insurer and reinsurer booked ...
Wildfires, Blackouts and Business Interruption in Today’s California
It was only expected to happen a couple times a year -- and just as a last resort. That's what utility giant PG&E Corp. originally said 13 months ago when it outlined plans to stage mass ...
Suit Alleging ‘Outrageous Conduct’ by AIG, Coventry Allowed to Proceed
An Alabama appellate court has cleared the way for a lawsuit that alleges outrageous and fraudulent conduct by American International Group and Coventry against a worker who was injured in an ...
Allergan Will Fork Over $750M to Settle Alzheimer’s Therapy Lawsuit
Allergan Plc would pay $750 million to settle a class action lawsuit from a group of direct purchasers of Alzheimer's disease therapy Namenda, the drugmaker said, in a resolution to the litigation ...